+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Drug Eluting Stent Market Size, Share & Trends Analysis Report by Type of Coating, End Use, Region, and Growth Forecasts, 2026-2033

  • PDF Icon

    Report

  • 150 Pages
  • April 2026
  • Region: Global
  • Grand View Research
  • ID: 5893161
The global drug eluting stent market size was estimated at USD 4.0 billion in 2025 and is projected to reach USD 6.7 billion by 2033, growing at a CAGR of 6.7% from 2026 to 2033. Market growth is primarily driven by the rising CVD prevalence, fueled by obesity, hypertension, diabetes, aging populations, sedentary lifestyles, and unhealthy diets. In October 2024, the CDC reported 919,032 deaths in the U.S. from cardiovascular disease in 2023, with coronary heart disease causing 371,506 deaths. About 1 in 6 CVD deaths occurred in adults under 65, and approximately 805,000 heart attacks happened nationwide, including 605,000 first-time events.

Rising Prevalence of Cardiovascular Diseases and Associated Risk Factors

The rising prevalence of cardiovascular diseases (CVDs) is a primary driver of the market. Increasing cases of coronary artery disease, heart failure, and peripheral artery disease are largely driven by lifestyle-related risk factors such as obesity, diabetes, hypertension, and sedentary behavior. As the global population ages, the demand for interventional procedures such as stenting, angioplasty, and catheter-based therapies continues to grow. In December 2025, the CDC released the 2024 adult obesity prevalence data for all U.S. states and territories. Obesity, defined as a BMI ≥30 kg/m², increases the risk of chronic diseases such as heart disease, diabetes, and certain cancers. Rates ranged from 25% to over 40%, highlighting the urgent need for prevention and treatment strategies across the population.

Increasing Volume of Percutaneous Coronary Intervention (PCI) Procedures

PCI is widely used to treat coronary artery disease and restore blood flow in narrowed or blocked coronary arteries. The increasing prevalence of cardiovascular diseases, including coronary artery disease and acute coronary syndromes, is raising the number of patients requiring interventional treatment. Higher incidence of risk factors such as hypertension, diabetes, and obesity further contributes to procedural demand. In May 2025, the SCAI Scientific Sessions reported that 408,060 outpatient PCI procedures (2020-2022) were analyzed, with 1.8% performed in ambulatory surgery centers and 98.2% in hospital outpatient departments. PCI use in ASCs rose to 0.87 per 10,000 person years, and 30 day adverse events, including mortality, stroke, and bleeding, remained below 2%.

Global Drug Eluting Stent Market Report Segmentation

This report forecasts revenue growth at global, regional & country levels and provides an analysis of the industry trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the global drug eluting stents market report based on type of coating, end use, and region:
  • Type of Coating Outlook (Volume, Thousand Units; Revenue, USD Million, 2021-2033)
  • Polymer-based Coating
  • Non-biodegradable Polymers
  • Biodegradable Polymers
  • Polymer-free Coating
  • Micro porous Surface
  • Micro structured Surface
  • Slotted tubular Surface
  • Nanoporous Surface
  • End Use Outlook (Volume, Thousand Units; Revenue, USD Million, 2021-2033)
  • Hospitals
  • Specialty Cardiac/Vascular Centers
  • Ambulatory Surgical Centers (ASCs)
  • Regional Outlook (Volume, Thousand Units; Revenue, USD Million, 2021-2033)
  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
  • Thailand
  • Indonesia
  • Malaysia
  • Vietnam
  • Latin America
  • Brazil
  • Argentina
  • Colombia
  • Chile
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Segment Scope
1.1.2. Estimates and Forecast Timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased Database
1.3.2. Internal Database
1.3.3. Secondary Sources
1.3.4. Primary Research
1.3.5. Details Of Primary Research
1.4. Information Or Data Analysis
1.4.1. Data Analysis Models
1.5. Market Formulation & Validation
1.6. Model Details
1.7. Research Assumptions
1.8. List of Secondary Sources
1.9. List of Primary Sources
Chapter 2. Drug Eluting Stent Market: Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Type of Coating Outlook
2.2.2. End Use Outlook
2.3. Competitive Insights
Chapter 3. Drug Eluting Stent Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.2.3. Market Opportunity Analysis
3.3. Global Drug Eluting Stents: Market Analysis Tools
3.3.1. Industry Analysis - Porter’s Five Force Analysis
3.3.2. PESTLE Analysis
3.4. Country-Level Market Driver Mapping
3.5. Market Entry Attractiveness Assessment
Chapter 4. Drug Eluting Stent Market Segment Analysis, by Type of Coating (Revenue in USD Million; Unit Volume in Thousand Units, 2021-2033)
4.1. Definition and Scope
4.2. Type of Coating Market Share Analysis, 2025 & 2033
4.3. Segment Dashboard
4.4. Global Drug Eluting Stents Market by Type of Coating Outlook
4.5. Market Size & Forecasts and Trend Analyses, 2021 To 2033 For the Following
4.5.1. Polymer-based Coating
4.5.2. Polymer-free Coating
Chapter 5. Drug Eluting Stent Market Segment Analysis, by End Use 2021-2033 (USD Million)
5.1. Definition and Scope
5.2. End Use Market Share Analysis, 2025 & 2033
5.3. Segment Dashboard
5.4. Global Drug Eluting Stents Market by End Use Outlook
5.5. Market Size & Forecasts and Trend Analyses, 2021 To 2033 For the Following
5.5.1. Hospitals
5.5.2. Specialty Cardiac/Vascular Centers
5.5.3. Ambulatory Surgical Centers (ASCs)
Chapter 6. Drug Eluting Stent Market Segment Analysis, by Region, (Revenue in USD Million; Unit Volume in Thousand Units, 2021-2033)
6.1. Regional Market Share Analysis, 2025 & 2033
6.2. Regional Market Dashboard
6.3. Global Regional Market Snapshot
6.4. Drug Eluting Stents Market Share by Region, 2025 & 2033:
6.5. North America
6.5.1. North America Drug Eluting Stents Market, 2021-2033 (USD Million)
6.5.2. U.S.
6.5.3. Canada
6.5.4. Mexico
6.6. Europe
6.6.1. Europe Drug Eluting Stents Market, 2021 To 2033 (USD Million)
6.6.2. UK
6.6.3. Germany
6.6.4. France
6.6.5. Italy
6.6.6. Spain
6.6.7. Denmark
6.6.8. Sweden
6.6.9. Norway
6.7. Asia-Pacific
6.7.1. China
6.7.2. Japan
6.7.3. India
6.7.4. Australia
6.7.5. South Korea
6.7.6. Thailand
6.7.7. Indonesia
6.7.8. Malaysia
6.7.9. Vietnam
6.8. Latin America
6.8.1. Latin America Drug Eluting Stents Market, 2021-2033 (USD Million)
6.8.2. Brazil
6.8.3. Argentina
6.8.4. Colombia
6.8.5. Chile
6.9. MEA
6.9.1. MEA Drug Eluting Stents Market, 2021-2033 (USD Million)
6.9.2. South Africa
6.9.3. Saudi Arabia
6.9.4. UAE
6.9.5. Kuwait
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, by Key Market Participants
7.2. Company Categorization (Key innovators, market leaders, emerging players)
7.3. Company Market Position Analysis, 2025
7.4. Company Market Share Analysis, 2025/2026 (%)
7.5. Company Profiles
7.5.1. Boston Scientific Corporation
7.5.2. Medtronic
7.5.3. Abbott
7.5.4. Teleflex Incorporated (BIOTRONIK)
7.5.5. Terumo Corporation
7.5.6. B. Braun SE
7.5.7. Translumina
7.5.8. MicroPort Scientific Corporation
7.5.9. Biosensors International Group, Ltd
7.5.10. Lepu Medical
7.5.11. iVascular S.L.U.
7.5.12. SMT
7.5.13. Meril Life Sciences Pvt. Ltd.
7.5.14. Concept Medical
7.5.15. Cardionovum GmbH
List of Tables
Table 1 List Of Secondary Sources
Table 2 List Of Abbreviations
Table 3 North America Drug Eluting Stents Market, by Region, 2021-2033 (USD Million)
Table 4 North America Drug Eluting Stents Market, by Type of Coating, 2021-2033 (USD Million)
Table 5 North America Drug Eluting Stents Market Estimates and Forecasts, by Type of Coating, 2021 To 2033 (Unit Volume, In Thousand Units)
Table 6 North America Drug Eluting Stents Market, by End Use, 2021-2033 (USD Million)
Table 7 U.S. Drug Eluting Stents Market, by Type of Coating, 2021-2033 (USD Million)
Table 8 U.S. Drug Eluting Stents Market Estimates and Forecasts, by Type of Coating, 2021 To 2033 (Unit Volume, In Thousand Units)
Table 9 U.S. Drug Eluting Stents Market, by End Use, 2021-2033 (USD Million)
Table 10 Canada Drug Eluting Stents Market, by Type of Coating, 2021-2033 (USD Million)
Table 11 Canada Drug Eluting Stents Market Estimates and Forecasts, by Type of Coating, 2021 To 2033 (Unit Volume, In Thousand Units)
Table 12 Canada Drug Eluting Stents Market, by End Use, 2021-2033 (USD Million)
Table 13 Mexico Drug Eluting Stents Market, by Type of Coating, 2021-2033 (USD Million)
Table 14 Mexico Drug Eluting Stents Market Estimates and Forecasts, by Type of Coating, 2021 To 2033 (Unit Volume, In Thousand Units)
Table 15 Mexico Drug Eluting Stents Market, by End Use, 2021-2033 (USD Million)
Table 16 Europe Drug Eluting Stents Market, Region, 2021-2033 (USD Million)
Table 17 Europe Drug Eluting Stents Market, by Type of Coating, 2021-2033 (USD Million)
Table 18 Europe Drug Eluting Stents Market Estimates and Forecasts, by Type of Coating, 2021 To 2033 (Unit Volume, In Thousand Units)
Table 19 Europe Drug Eluting Stents Market, by End Use, 2021-2033 (USD Million)
Table 20 UK Drug Eluting Stents Market, by Type of Coating, 2021-2033 (USD Million)
Table 21 UK Drug Eluting Stents Market, by Type of Coating, 2021 To 2033 (Unit Volume, In Thousand Units)
Table 22 UK Drug Eluting Stents Market, by End Use, 2021-2033 (USD Million)
Table 23 Germany Drug Eluting Stents Market, by Type of Coating, 2021-2033 (USD Million)
Table 24 Germany Drug Eluting Stents Market Estimates and Forecasts, by Type of Coating, 2021 To 2033 (Unit Volume, In Thousand Units)
Table 25 Germany Drug Eluting Stents Market, by End Use, 2021-2033 (USD Million)
Table 26 France Drug Eluting Stents Market, by Type of Coating, 2021-2033 (USD Million)
Table 27 France Drug Eluting Stents Market Estimates and Forecasts, by Type of Coating, 2021 To 2033 (Unit Volume, In Thousand Units)
Table 28 France Drug Eluting Stents Market, by End Use, 2021-2033 (USD Million)
Table 29 Italy Drug Eluting Stents Market, by Type of Coating, 2021-2033 (USD Million)
Table 30 Italy Drug Eluting Stents Market Estimates and Forecasts, by Type of Coating, 2021 To 2033 (Unit Volume, In Thousand Units)
Table 31 Italy Drug Eluting Stents Market, by End Use, 2021-2033 (USD Million)
Table 32 Spain Drug Eluting Stents Market, by Type of Coating, 2021-2033 (USD Million)
Table 33 Spain Drug Eluting Stents Market Estimates and Forecasts, by Type of Coating, 2021 To 2033 (Unit Volume, In Thousand Units)
Table 34 Spain Drug Eluting Stents Market, by End Use 2021-2033 (USD Million)
Table 35 Denmark Drug Eluting Stents Market, by Type of Coating, 2021-2033 (USD Million)
Table 36 Denmark Drug Eluting Stents Market Estimates and, by Type of Coating, 2021 To 2033 (Unit Volume, In Thousand Units)
Table 37 Denmark Drug Eluting Stents Market, by End Use, 2021-2033 (USD Million)
Table 38 Sweden Drug Eluting Stents Market, by Type of Coating, 2021-2033 (USD Million)
Table 39 Sweden Drug Eluting Stents Market Estimates and Forecasts, by Type of Coating, 2021 To 2033 (Unit Volume, In Thousand Units)
Table 40 Sweden Drug Eluting Stents Market, by End Use, 2021-2033 (USD Million)
Table 41 Norway Drug Eluting Stents Market, by Type of Coating, 2021-2033 (USD Million)
Table 42 Norway Drug Eluting Stents Market Estimates and Forecasts, by Type of Coating, 2021 To 2033 (Unit Volume, In Thousand Units)
Table 43 Norway Drug Eluting Stents Market, by End Use, 2021-2033 (USD Million)
Table 44 Asia-Pacific Drug Eluting Stents Market, Region, 2021-2033 (USD Million)
Table 45 Asia-Pacific Drug Eluting Stents Market, by Type of Coating, 2021-2033 (USD Million)
Table 46 Asia-Pacific Drug Eluting Stents Market Estimates and Forecasts, by Type of Coating, 2021 To 2033 (Unit Volume, In Thousand Units)
Table 47 Asia-Pacific Drug Eluting Stents Market, by End Use, 2021-2033 (USD Million)
Table 48 China Drug Eluting Stents Market, by Type of Coating, 2021-2033 (USD Million)
Table 49 China Drug Eluting Stents Market Estimates and Forecasts, by Type of Coating, 2021 To 2033 (Unit Volume, In Thousand Units)
Table 50 China Drug Eluting Stents Market, by End Use 2021-2033 (USD Million)
Table 51 Japan Drug Eluting Stents Market, by Type of Coating, 2021-2033 (USD Million)
Table 52 Japan Drug Eluting Stents Market Estimates and Forecasts, by Type of Coating, 2021 To 2033 (Unit Volume, In Thousand Units)
Table 53 Japan Drug Eluting Stents Market, by End Use, 2021-2033 (USD Million)
Table 54 India Drug Eluting Stents Market, by Type of Coating, 2021-2033 (USD Million)
Table 55 India Drug Eluting Stents Market Estimates and Forecasts, by Type of Coating, 2021 To 2033 (Unit Volume, In Thousand Units)
Table 56 India Drug Eluting Stents Market, by End Use, 2021-2033 (USD Million)
Table 57 Australia Drug Eluting Stents Market, by Type of Coating, 2021-2033 (USD Million)
Table 58 Australia Drug Eluting Stents Market Estimates and Forecasts, by Type of Coating, 2021 To 2033 (Unit Volume, In Thousand Units)
Table 59 Australia Drug Eluting Stents Market, by End Use 2021-2033 (USD Million)
Table 60 South Korea Drug Eluting Stents Market, by Type of Coating, 2021-2033 (USD Million)
Table 61 South Korea Drug Eluting Stents Market Estimates and Forecasts, by Type of Coating, 2021 To 2033 (Unit Volume, In Thousand Units)
Table 62 South Korea Drug Eluting Stents Market, by End Use, 2021-2033 (USD Million)
Table 63 Thailand Drug Eluting Stents Market, by Type of Coating, 2021-2033 (USD Million)
Table 64 Thailand Drug Eluting Stents Market Estimates and Forecasts, by Type of Coating, 2021 To 2033 (Unit Volume, In Thousand Units)
Table 65 Thailand Drug Eluting Stents Market, by End Use, 2021-2033 (USD Million)
Table 66 Indonesia Drug Eluting Stents Market, by Type of Coating, 2021-2033 (USD Million)
Table 67 Indonesia Drug Eluting Stents Market Estimates and Forecasts, by Type of Coating, 2021 To 2033 (Unit Volume, In Thousand Units)
Table 68 Indonesia Drug Eluting Stents Market, by End Use, 2021-2033 (USD Million)
Table 69 Malaysia Drug Eluting Stents Market, by Type of Coating, 2021-2033 (USD Million)
Table 70 Malaysia Drug Eluting Stents Market Estimates and Forecasts, by Type of Coating, 2021 To 2033 (Unit Volume, In Thousand Units)
Table 71 Malaysia Drug Eluting Stents Market, by End Use, 2021-2033 (USD Million)
Table 72 Vietnam Drug Eluting Stents Market, by Type of Coating, 2021-2033 (USD Million)
Table 73 Vietnam Drug Eluting Stents Market Estimates and Forecasts, by Type of Coating, 2021 To 2033 (Unit Volume, In Thousand Units)
Table 74 Vietnam Drug Eluting Stents Market, by End Use, 2021-2033 (USD Million)
Table 75 Latin America Drug Eluting Stents Market, Region, 2021-2033 (USD Million)
Table 76 Latin America Drug Eluting Stents Market, by Type of Coating, 2021-2033 (USD Million)
Table 77 Latin America Drug Eluting Stents Market Estimates and Forecasts, by Type of Coating, 2021 To 2033 (Unit Volume, In Thousand Units)
Table 78 Latin America Drug Eluting Stents Market, by End Use, 2021-2033 (USD Million)
Table 79 Brazil Drug Eluting Stents Market, by Type of Coating, 2021-2033 (USD Million)
Table 80 Brazil Drug Eluting Stents Market Estimates and Forecasts, by Type of Coating, 2021 To 2033 (Unit Volume, In Thousand Units)
Table 81 Brazil Drug Eluting Stents Market, by End Use 2021-2033 (USD Million)
Table 82 Argentina Drug Eluting Stents Market, by Type of Coating, 2021-2033 (USD Million)
Table 83 Argentina Drug Eluting Stents Market Estimates and Forecasts, by Type of Coating, 2021 To 2033 (Unit Volume, In Thousand Units)
Table 84 Argentina Drug Eluting Stents Market, by End Use, 2021-2033 (USD Million)
Table 85 Colombia Drug Eluting Stents Market, by Type of Coating, 2021-2033 (USD Million)
Table 86 Colombia Drug Eluting Stents Market Estimates and Forecasts, by Type of Coating, 2021 To 2033 (Unit Volume, In Thousand Units)
Table 87 Colombia Drug Eluting Stents Market, by End Use, 2021-2033 (USD Million)
Table 88 Chile Drug Eluting Stents Market, by Type of Coating, 2021-2033 (USD Million)
Table 89 Chile Drug Eluting Stents Market Estimates and Forecasts, by Type of Coating, 2021 To 2033 (Unit Volume, In Thousand Units)
Table 90 Chile Drug Eluting Stents Market, by End Use, 2021-2033 (USD Million)
Table 91 MEA Drug Eluting Stents Market, Region, 2021-2033 (USD Million)
Table 92 MEA Drug Eluting Stents Market, by Type of Coating, 2021-2033 (USD Million)
Table 93 MEA Drug Eluting Stents Market Estimates and Forecasts, by Type of Coating, 2021 To 2033 (Unit Volume, In Thousand Units)
Table 94 MEA Drug Eluting Stents Market, by End Use, 2021-2033 (USD Million)
Table 95 South Africa Drug Eluting Stents Market, by Type of Coating, 2021-2033 (USD Million)
Table 96 South Africa Drug Eluting Stents Market Estimates and Forecasts, by Type of Coating, 2021 To 2033 (Unit Volume, In Thousand Units)
Table 97 South Africa Drug Eluting Stents Market, by End Use, 2021-2033 (USD Million)
Table 98 Saudi Arabia Drug Eluting Stents Market, by Type of Coating, 2021-2033 (USD Million)
Table 99 Saudi Arabia Drug Eluting Stents Market Estimates and Forecasts, by Type of Coating, 2021 To 2033 (Unit Volume, In Thousand Units)
Table 100 Saudi Arabia Drug Eluting Stents Market, by End Use 2021-2033 (USD Million)
Table 101 UAE Drug Eluting Stents Market, by Type of Coating, 2021-2033 (USD Million)
Table 102 UAE Drug Eluting Stents Market Estimates and Forecasts, by Type of Coating, 2021 To 2033 (Unit Volume, In Thousand Units)
Table 103 UAE Drug Eluting Stents Market, by End Use, 2021-2033 (USD Million)
Table 104 Kuwait Drug Eluting Stents Market, by Type of Coating, 2021-2033 (USD Million)
Table 105 Kuwait Drug Eluting Stents Market Estimates and Forecasts, by Type of Coating, 2021 To 2033 (Unit Volume, In Thousand Units)
Table 106 Kuwait Drug Eluting Stents Market, by End Use, 2021-2033 (USD Million)
List of Figures
Figure 1 Market Research Process
Figure 2 Data Triangulation Techniques
Figure 3 Primary Research Pattern
Figure 4 Market Research Approaches
Figure 5 Value-Chain-Based Sizing & Forecasting
Figure 6 QFD Modeling For Market Share Assessment
Figure 7 Market Formulation & Validation
Figure 8 Drug Eluting Stents Market: Market Outlook
Figure 9 Drug Eluting Stents Competitive Insights
Figure 10 Parent Market Outlook
Figure 11 Ancillary Market Outlook
Figure 12 Global Drug Eluting Stents Market Driver Impact
Figure 13 Global Drug Eluting Stents Market Restraint Impact
Figure 14 Porter’s Five Force’s Analysis
Figure 15 PESTLE Analysis
Figure 16 Drug Eluting Stents Market: Type of Coating Movement Analysis
Figure 17 Drug Eluting Stents Market: Type of Coating Outlook and Key Takeaways
Figure 18 Polymer-based Coating Market Estimates and Forecast, 2021-2033 (Revenue in USD Million; Unit Volume in Thousand Units)
Figure 19 Non-biodegradable Polymers Market Estimates and Forecast, 2021-2033 (Revenue in USD Million; Unit Volume in Thousand Units)
Figure 20 Biodegradable Polymers Market Estimates and Forecast, 2021-2033 (Revenue in USD Million; Unit Volume in Thousand Units)
Figure 21 Polymer-free Coating Market Estimates and Forecast, 2021-2033 (Revenue in USD Million; Unit Volume in Thousand Units)
Figure 22 Micro Porous Surface Market Estimates and Forecast, 2021-2033 (Revenue in USD Million; Unit Volume in Thousand Units)
Figure 23 Micro Structured Surface Market Estimates and Forecast, 2021-2033 (Revenue in USD Million; Unit Volume in Thousand Units)
Figure 24 Slotted Tubular Surface Market Estimates and Forecast, 2021-2033 (Revenue in USD Million; Unit Volume in Thousand Units)
Figure 25 Nanoporous Surface Market Estimates and Forecast, 2021-2033 (Revenue in USD Million; Unit Volume in Thousand Units)
Figure 26 Drug Eluting Stents Market: End Use Movement Analysis
Figure 27 Drug Eluting Stents Market: End Use Outlook and Key Takeaways
Figure 28 Hospitals Market Estimates and Forecast, 2021-2033
Figure 29 Specialty Cardiac/Vascular Centers Market Estimates and Forecast, 2021-2033
Figure 30 Ambulatory Surgical Centers (ASCs) Market Estimates and Forecast, 2021-2033
Figure 31 Global Drug Eluting Stents Market: Regional Movement Analysis
Figure 32 Global Drug Eluting Stents Market: Regional Outlook and Key Takeaways
Figure 33 North America Drug Eluting Stents Market Estimates and Forecast, 2021-2033 (Revenue in USD Million; Unit Volume in Thousand Units)
Figure 34 Key Country Dynamics
Figure 35 U.S. Drug Eluting Stents Market Estimates and Forecast, 2021-2033 (Revenue in USD Million; Unit Volume in Thousand Units)
Figure 36 Key Country Dynamics
Figure 37 Canada Drug Eluting Stents Market Estimates and Forecast, 2021-2033 (Revenue in USD Million; Unit Volume in Thousand Units)
Figure 38 Key Country Dynamics
Figure 39 Mexico Drug Eluting Stents Market Estimates and Forecast, 2021-2033 (Revenue in USD Million; Unit Volume in Thousand Units)
Figure 40 Europe Drug Eluting Stents Market Estimates and Forecast, 2021-2033 (Revenue in USD Million; Unit Volume in Thousand Units)
Figure 41 Key Country Dynamics
Figure 42 UK Drug Eluting Stents Market Estimates and Forecast, 2021-2033 (Revenue in USD Million; Unit Volume in Thousand Units)
Figure 43 Key Country Dynamics
Figure 44 Germany Drug Eluting Stents Market Estimates and Forecast, 2021-2033 (Revenue in USD Million; Unit Volume in Thousand Units)
Figure 45 Key Country Dynamics
Figure 46 France Drug Eluting Stents Market Estimates and Forecast, 2021-2033 (Revenue in USD Million; Unit Volume in Thousand Units)
Figure 47 Key Country Dynamics
Figure 48 Italy Drug Eluting Stents Market Estimates and Forecast, 2021-2033 (Revenue in USD Million; Unit Volume in Thousand Units)
Figure 49 Key Country Dynamics
Figure 50 Spain Drug Eluting Stents Market Estimates and Forecast, 2021-2033 (Revenue in USD Million; Unit Volume in Thousand Units)
Figure 51 Key Country Dynamics
Figure 52 Denmark Drug Eluting Stents Market Estimates and Forecast, 2021-2033 (Revenue in USD Million; Unit Volume in Thousand Units)
Figure 53 Key Country Dynamics
Figure 54 Sweden Drug Eluting Stents Market Estimates and Forecast, 2021-2033 (Revenue in USD Million; Unit Volume in Thousand Units)
Figure 55 Norway Drug Eluting Stents Market Estimates and Forecast, 2021-2033 (USD million)
Figure 56 Key Country Dynamics
Figure 57 Asia-Pacific Drug Eluting Stents Market Estimates and Forecast, 2021-2033 (Revenue in USD Million; Unit Volume in Thousand Units)
Figure 58 Key Country Dynamics
Figure 59 China Drug Eluting Stents Market Estimates and Forecast, 2021-2033 (Revenue in USD Million; Unit Volume in Thousand Units)
Figure 60 Key Country Dynamics
Figure 61 Japan Drug Eluting Stents Market Estimates and Forecast, 2021-2033 (Revenue in USD Million; Unit Volume in Thousand Units)
Figure 62 Key Country Dynamics
Figure 63 India Drug Eluting Stents Market Estimates and Forecast, 2021-2033 (Revenue in USD Million; Unit Volume in Thousand Units)
Figure 64 Key Country Dynamics
Figure 65 Australia Drug Eluting Stents Market Estimates and Forecast, 2021-2033 (Revenue in USD Million; Unit Volume in Thousand Units)
Figure 66 Key Country Dynamics
Figure 67 South Korea Drug Eluting Stents Market Estimates and Forecast, 2021-2033 (Revenue in USD Million; Unit Volume in Thousand Units)
Figure 68 Key Country Dynamics
Figure 69 Thailand Drug Eluting Stents Market Estimates and Forecast, 2021-2033 (Revenue in USD Million; Unit Volume in Thousand Units)
Figure 70 Key Country Dynamics
Figure 71 Indonesia Drug Eluting Stents Market Estimates and Forecast, 2021-2033 (Revenue in USD Million; Unit Volume in Thousand Units)
Figure 72 Key Country Dynamics
Figure 73 Malaysia Drug Eluting Stents Market Estimates and Forecast, 2021-2033 (Revenue in USD Million; Unit Volume in Thousand Units)
Figure 74 Key Country Dynamics
Figure 75 Vietnam Drug Eluting Stents Market Estimates and Forecast, 2021-2033 (Revenue in USD Million; Unit Volume in Thousand Units)
Figure 76 Key Country Dynamics
Figure 77 Latin America Drug Eluting Stents Market Estimates and Forecast, 2021-2033 (Revenue in USD Million; Unit Volume in Thousand Units)
Figure 78 Key Country Dynamics
Figure 79 Brazil Drug Eluting Stents Market Estimates and Forecast, 2021-2033 (Revenue in USD Million; Unit Volume in Thousand Units)
Figure 80 Key Country Dynamics
Figure 81 Argentina Drug Eluting Stents Market Estimates and Forecast, 2021-2033 (Revenue in USD Million; Unit Volume in Thousand Units)
Figure 82 Key Country Dynamics
Figure 83 Colombia Drug Eluting Stents Market Estimates and Forecast, 2021-2033 (Revenue in USD Million; Unit Volume in Thousand Units)
Figure 84 Key Country Dynamics
Figure 85 Chile Drug Eluting Stents Market Estimates and Forecast, 2021-2033 (Revenue in USD Million; Unit Volume in Thousand Units)
Figure 86 Key Country Dynamics
Figure 87 MEA Drug Eluting Stents Market Estimates and Forecast, 2021-2033 (Revenue in USD Million; Unit Volume in Thousand Units)
Figure 88 Key Country Dynamics
Figure 89 South Africa Drug Eluting Stents Market Estimates and Forecast, 2021-2033 (Revenue in USD Million; Unit Volume in Thousand Units)
Figure 90 Key Country Dynamics
Figure 91 Saudi Arabia Drug Eluting Stents Market Estimates and Forecast, 2021-2033 (Revenue in USD Million; Unit Volume in Thousand Units)
Figure 92 Key Country Dynamics
Figure 93 UAE Drug Eluting Stents Market Estimates and Forecast, 2021-2033 (Revenue in USD Million; Unit Volume in Thousand Units)
Figure 94 Key Country Dynamics
Figure 95 Kuwait Drug Eluting Stents Market Estimates and Forecast, 2021-2033 (Revenue in USD Million; Unit Volume in Thousand Units)
Figure 96 Key Country Dynamics
Figure 97 Key company categorization
Figure 98 Heat map analysis 2025

Companies Mentioned

  • Boston Scientific Corporation
  • Medtronic
  • Abbott
  • Teleflex Incorporated (BIOTRONIK)
  • Terumo Corporation
  • B. Braun SE
  • Translumina
  • MicroPort Scientific Corporation
  • Biosensors International Group, Ltd
  • Lepu Medical
  • iVascular S.L.U.
  • SMT
  • Meril Life Sciences Pvt. Ltd.
  • Concept Medical
  • Cardionovum GmbH

Table Information